Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Published on by Global Scholar Awards

Prof. Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Assistant Professor | Zhejiang University School of Medicine | China

Sakarie Mustafe Hidig is a researcher at Zhejiang University, Hangzhou, China, specializing in biomaterials, drug delivery systems, and immunotherapeutic strategies for cancer treatment. His research focuses on the design of functional polymer-based platforms particularly chitosan hydrogels and boronated diol drug conjugates aimed at enhancing therapeutic efficacy while stimulating robust anti-tumor immune responses. His recent work on a versatile chitosan hydrogel for hepatocellular carcinoma demonstrates a powerful fusion of material science and immune engineering, offering new avenues for more effective and biocompatible cancer therapies. Dr. Hidig has authored 7 peer-reviewed publications, earning 12 citations and maintaining an h-index of 2, reflecting his early but steadily increasing scholarly impact. With collaborations spanning 27 international co-authors, he engages actively in multidisciplinary research that advances innovative, targeted, and safer therapeutic solutions. His contributions address global health priorities by developing responsive materials capable of improving clinical outcomes, reducing toxicity, and shaping the future landscape of cancer treatment technologies.

Profiles: Scopus | ORCID

Featured Publications

1. Hidg, S. M., & Samatar, H. (2025). Optimal timing of percutaneous transhepatic gallbladder drainage in high-risk acute cholecystitis patients and its impact on elective laparoscopic cholecystectomy. RGUHS Journal of Medical Sciences, 15(1), 32–42.

2. Fatima, B., Rubab, N., Mujahid, M. U. F. M., & Hidig, S. M. (2025). A large pediatric retroperitoneal benign lipoma in a 2-year-old female: A case report and literature review. Medicine, December 5, 2025.

3. Hidig, S. M., Mujahid, M. U. F. M., Jie, Y., & Hu, Z. (2025). Status epilepticus and stethoscopes: The struggle and strategy of doctors in the management of status epilepticus in long-term modern warfare conflict settings. Epileptic Disorders, 2025.

4. Yang, S., Zhang, E., Li, Z., Long, Y., Li, Y., Zhang, J., Wang, F., Liu, L., Wang, T., Guo, J., & Hou, Z. (2025). Deep vein thrombosis in patients with patellar fractures: Assessing incidence rates and identifying risk factors. PLOS ONE, 20(2), e0316628.

5. Hidig, S. M., Kakule Kitaghenda, F., & Samatar, H. (2025). Assessing the role of Helicobacter pylori in cholelithiasis development: A meta-analytical approach. Greenfort International Journal of Applied Medical Science, 3(01), Article 004.

German Soriano | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. German Soriano | Medicine and Dentistry | Best Researcher Award

Chief of hospitalisation, Department of Gastroenterology at Hospital de la Santa Creu i Sant Pau , Spain

Dr. Germán Soriano Pastor, a senior consultant in Digestive Pathology at Hospital de la Santa Creu i Sant Pau, is a distinguished clinician-researcher with over three decades of experience. His research has significantly advanced understanding of cirrhosis, focusing on bacterial infections, immune dysfunction, microbiota, and frailty. He has led pivotal studies exploring alternatives to antibiotics, particularly probiotics, and developed therapeutic programs to improve frailty in cirrhotic patients. With over 160 scientific publications—many in top-tier journals—and an H-index of 59, his work is widely recognized. He has also collaborated internationally, contributed to major liver disease consortia, and mentored young researchers. As the new head of the CIBERehd group at his institution, Dr. Soriano demonstrates leadership, innovation, and a strong commitment to multidisciplinary research. These achievements make him a highly suitable candidate for the Best Researcher Award, though continued expansion into emerging areas and technological methodologies could further elevate his impact.

Professional Profile

Education🎓

Dr. Germán Soriano Pastor has a strong educational foundation that underpins his distinguished medical and research career. He earned his medical degree from a reputable Spanish university, where he demonstrated early academic excellence and a keen interest in hepatology. He completed his specialization in Digestive Pathology at the Hospital de la Santa Creu i Sant Pau in Barcelona, a leading institution in clinical and research training. Driven by a passion for advancing liver disease research, he pursued further academic development through various postgraduate training programs, workshops, and international fellowships, which enriched his expertise in cirrhosis, microbiota, and liver-related infections. His educational journey has been marked by a commitment to continuous learning and innovation, enabling him to stay at the forefront of medical advancements. Dr. Soriano’s educational background has not only equipped him with deep clinical knowledge but also positioned him to mentor the next generation of researchers and healthcare professionals effectively.

Professional Experience📝

Dr. Germán Soriano Pastor has extensive professional experience in the field of hepatology, with a focus on cirrhosis, liver infections, and microbiota. He currently serves as a researcher and physician at the Hospital Universitari Vall d’Hebron in Barcelona, where he is an integral member of the Liver Unit. Dr. Soriano has led and participated in numerous clinical trials and translational research projects, significantly contributing to the understanding of complications in cirrhotic patients. His work bridges clinical practice and scientific research, ensuring that patient care is informed by the latest evidence-based findings. Over the years, he has published extensively in high-impact medical journals and presented at international conferences. He is also actively involved in teaching and mentoring medical residents and fellows, fostering a collaborative and educational environment. His professional journey reflects a strong commitment to improving outcomes for liver disease patients through innovation, research excellence, and compassionate clinical care.

Research Interest🔎

Dr. Germán Soriano Pastor’s research interests are centered on the complications of liver cirrhosis, particularly infections and their relationship with the gut microbiota and immune dysfunction. He is deeply involved in exploring how bacterial translocation and microbial imbalance contribute to the progression of liver disease and impact patient outcomes. His work focuses on identifying biomarkers for early detection of infections and organ failure in cirrhotic patients, aiming to improve prognostic accuracy and guide therapeutic interventions. Dr. Soriano is also interested in investigating the role of novel antimicrobial strategies and the modulation of microbiota as potential treatments. His translational research bridges the gap between laboratory discoveries and clinical applications, striving to develop personalized medicine approaches in hepatology. Through his research, Dr. Soriano aims to advance the understanding of liver disease pathophysiology, reduce complications, and enhance quality of life and survival rates for patients with advanced liver disease.

Award and Honor🏆

Dr. Germán Soriano Pastor has been the recipient of numerous prestigious awards and honors in recognition of his contributions to hepatology and medical research. His excellence in clinical research has earned him accolades from leading medical societies, including awards for best scientific presentations at international conferences. He has received competitive research grants and fellowships from renowned institutions, underscoring the impact and innovation of his work on liver disease and its complications. Dr. Soriano’s commitment to advancing medical knowledge has also been recognized through invitations to serve as a reviewer and editorial board member for high-impact scientific journals. Additionally, he has been honored by academic institutions for his teaching and mentorship roles, reflecting his dedication to shaping the next generation of medical professionals. These distinctions highlight Dr. Soriano’s standing as a respected expert in his field and affirm the significance of his ongoing contributions to science and patient care.

Research Skill🔬

Dr. Germán Soriano Pastor possesses a comprehensive and well-honed set of research skills that have significantly contributed to advancements in hepatology. His expertise spans clinical research design, epidemiological analysis, and the implementation of translational studies focused on liver diseases. He is adept in utilizing advanced statistical tools and methodologies to analyze complex datasets, ensuring the reliability and validity of his findings. Dr. Soriano excels in conducting multicenter clinical trials and observational studies, particularly those investigating the complications of cirrhosis, portal hypertension, and liver transplantation outcomes. His skills in systematic review and evidence synthesis allow him to draw robust conclusions that inform clinical practice. Additionally, his proficiency in scientific writing and communication has enabled him to publish extensively in peer-reviewed journals and present at international conferences. His collaborative approach and leadership in multidisciplinary research teams further reflect his ability to drive impactful studies that bridge clinical practice and scientific discovery.

Conclusion💡

Dr. Germán Soriano Pastor stands out as a mature, accomplished, and influential researcher whose sustained contributions in hepatology, especially in cirrhosis and MASLD, have had a tangible impact on clinical practice and patient care. His scientific output, leadership, interdisciplinary collaboration, and focus on clinically relevant issues make him an outstanding candidate for the Best Researcher Award.

Publications Top Noted✍

  • Title: Human albumin administration at the time of large volume paracentesis: A modified Delphi study
    Authors: Y.M. Ibrahim, E.B. Tapper, J.P.H. Drenth, S. Verma, F.S.H. Wong
    Year: 2025
    Citations: 1

  • Title: Comparison of Bacterial Infections in Patients With Cirrhosis Between Hospitals With and Without Liver Transplant in Catalonia
    Authors: C. Torras, J. Bañares, A. Martí-Carretero, O. Gasch, C. Solè
    Year: 2025
    Citations: 0

  • Title: Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults
    Authors: T. Laue, M.P. Ballester, L. Meoli, E. Nicastro, N.M. Rock
    Year: 2025
    Citations: 0

  • Title: Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: A global study
    Authors: F. Idalsoaga, L.A. Diaz, W. Dunn, R.A. Bataller, J.P. Arab
    Year: 2025
    Citations: 0

  • Title: Moderate alcohol-associated hepatitis: A real-world multicenter study
    Authors: F. Idalsoaga, L.A. Diaz, W. Dunn, R.A. Bataller, J.P. Arab
    Year: 2025
    Citations: 0

  • Title: Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial
    Authors: E. Pose, C. Jiménez, G. Zaccherini, P.S. Kamath, P. Giǹes
    Year: 2025
    Citations: 1

  • Title: Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty
    Authors: R. Díaz-Ruiz, M. Poca, E.M. Román, G. Soriano, R. García-Martínez
    Year: 2025
    Citations: 0

  • Title: Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
    Authors: R. Díaz-Ruiz, M. Poca, E.M. Román, G. Soriano, R. García-Martínez
    Year: 2025
    Citations: 1

  • Title: Impact of the COVID-19 pandemic on the incidence and type of infections in hospitalized patients with cirrhosis: a retrospective study
    Authors: B. Cuyas, A. Huerta, M. Poca, À. Escorsell, G. Soriano
    Year: 2024
    Citations: 0

  • Title: Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics
    Authors: L. Laghi, M.A. Ortiz, R.F. Giacomo, À. Escorsell, G. Soriano
    Year: 2024
    Citations: 0

 

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O